Cellectar Biosciences, Inc. (CLRB)
3.39
+0.18
(+5.61%)
USD |
NASDAQ |
Feb 10, 16:00
3.39
0.00 (0.00%)
After-Hours: 17:30
Cellectar Biosciences Shareholders Equity (Quarterly) : 9.379M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Imunon, Inc. | 4.082M |
| PDS Biotechnology Corp. | 9.454M |
| PAVmed, Inc. | 35.78M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.63M |
| Total Liabilities (Quarterly) | 5.248M |
| Debt to Equity Ratio | 0.046 |
| Current Ratio | 2.773 |
| Net Debt Paydown Yield | 0.20% |